Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL18670804 | 0.98 | KDM4E (0.34) | KDM4ETP53 | |
| SCHEMBL30604624 | 0.98 | KDM4E (0.34) | KDM4ETP53 | |
| SCHEMBL28999623 | 0.94 | KDM4E (0.32) | KDM4ETP53 | |
| SCHEMBL28999633 | 0.92 | KDM4E (0.32) | KDM4ETP53 | |
| SCHEMBL10142595 | 0.82 | KDM4E (0.44) | KDM4ETP53TDP1NPC1ALDH1A1 | |
| SCHEMBL1007639 | 0.79 | — | — | |
| SCHEMBL27755744 | 0.76 | METAP2 (0.36) | — | |
| SCHEMBL87533 | 0.76 | — | — | |
| SCHEMBL503234 | 0.76 | KDM4E (0.61) | KDM4ETP53TDP1NPC1ALDH1A1 | |
| SCHEMBL10882681 | 0.74 | MEN1 (0.33) | NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023205507-A1 | ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE | ESSA PHARMA INC. (CA) | 2023-10-26 | — | — | WO | claimed |
| CN-116082410-A | Bidentate pyrimidinyl triazole carbene palladium hydrated 3-pyridine sulfonate compound, and preparation method and application thereof | 江苏科技大学 | 2023-05-09 | — | — | CN | claimed |
| CN-101553232-A | Kinase inhibitors useful for the treatment of proliferative diseases | DECIPHERA PHARMACEUTICALS LLC (US) | 2009-10-07 | — | — | CN | claimed |
| CN-101553233-A | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases | DECIPHERA PHARMACEUTICALS LLC (US) | 2009-10-07 | — | — | CN | claimed |
| CN-101516379-A | Kinase inhibitors useful for the treatment of proliferative diseases | DECIPHERA PHARMACEUTICALS LLC (US) | 2009-08-26 | — | — | CN | claimed |
| US-20050143578-A1 | Compounds and methods | SMITHKLINE BEECHAM CORPORATION | 2005-06-30 | — | — | US | claimed |
| EP-1434772-A4 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORP (US) | 2005-05-04 | — | — | EP | claimed |
| US-20040192914-A1 | Compounds and methods | SMITHKLINE BEECHAM CORPORATION | 2004-09-30 | — | — | US | claimed |
| EP-1434772-A1 | COMPOUNDS AND METHODS | SmithKline Beecham Corporation (US) | 2004-07-07 | — | — | EP | claimed |
| WO-2003031434-A1 | COMPOUNDS AND METHODS | SMITH KLINE BEECHAM CORPORATION (US) | 2003-04-17 | — | — | WO | claimed |
| EP-0116341-B1 | 2H-V-TRIAZOLYL(4,5-D)-PYRIMIDINES AND THEIR USE | BASF Aktiengesellschaft (DE) | 1986-05-07 | — | — | EP | claimed |
| EP-0116341-A1 | 2H-V-Triazolyl(4,5-D)-pyrimidines and their use | BASF Aktiengesellschaft (DE) | 1984-08-22 | — | — | EP | claimed |
| EP-4414364-A4 | PYRIMIDINYL TRIAZOLE COMPOUND OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAID COMPOUND AS ACTIVE INGREDIENT, AND PEST CONTROL METHOD | NIHON NOHYAKU CO LTD (JP) | 2025-09-24 | — | — | EP | disclosed |
| US-20250228241-A1 | PYRIMIDINYL TRIAZOLE COMPOUND OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAID COMPOUND AS ACTIVE INGREDIENT, AND PEST CONTROL METHOD | NIHON NOHYAKU CO., LTD. (JP) | 2025-07-17 | — | — | US | disclosed |
| US-20250228241-A1 | PYRIMIDINYL TRIAZOLE COMPOUND OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAID COMPOUND AS ACTIVE INGREDIENT, AND PEST CONTROL METHOD | NIHON NOHYAKU CO., LTD. (JP) | 2025-07-17 | — | — | US | disclosed |
| CN-116082410-B | Bidentate pyrimidinyl triazole carbene palladium hydrated 3-pyridine sulfonate compound, and preparation method and application thereof | 江苏科技大学 | 2025-07-15 | — | — | CN | disclosed |
| EP-0116341-A1 | 2H-V-Triazolyl(4,5-D)-pyrimidines and their use | BASF Aktiengesellschaft (DE) | 1984-08-22 | — | — | EP | disclosed |
| US-4302586-A | FLUORESCENT WHITENERS | CIBA-GEIGY CORPORATION (US) | 1981-11-24 | — | — | US | disclosed |
| US-4302586-A | FLUORESCENT WHITENERS | CIBA-GEIGY CORPORATION (US) | 1981-11-24 | — | — | US | disclosed |
| US-4269980-A | TRANQUILIZERS; ANTICONVULSANTS | AMERICAN CYANAMID COMPANY (US) | 1981-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192914-A1 | Compounds and methods | METAP2, METAP1, DNPEP | KDM4E 1697/4885TP53 1686/4885CLK4 4445/4885 |
| US-20050143578-A1 | Compounds and methods | METAP2, METAP1, DNPEP | KDM4E 1531/4885TP53 1822/4885CLK4 4468/4885 |
| US-20250228241-A1 | PYRIMIDINYL TRIAZOLE COMPOUND OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAID COMPOUND AS ACTIVE INGREDIENT, AND PEST CONTROL METHOD | WASHC5, TAC3, PSTPIP2 | KDM4E 1371/4885TP53 4173/4885CLK4 3881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.